G. Urquhart

Epstein‐Barr virus, B cell lymphoproliferative disease, and SCID mice: Modeling T cell immunotherapy in vivo

L. Bieleski, D. Crawford, I. Johannessen, 2011, Journal of medical virology.

trial lymphoproliferative disease: results of a phase 2 multicenter clinical Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation

A. Swerdlow, M. Gandhi, M. Turner, 2013 .

Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial.

A. Swerdlow, M. Gandhi, M. Turner, 2007, Blood.

Epitope Specificity and Clonality of EBV-Specific CTLs Used to Treat Posttransplant Lymphoproliferative Disease1

C. Bellamy, D. Crawford, T. Haque, 2009, The Journal of Immunology.